Speakers

• Reuven Agami

  The Netherlands Cancer Institute
  Amsterdam (The Netherlands)

• Denise Barlow

  Research Center for Molecular Medicine of the Austrian Academy of Science (Ce-M-M) and the University of Vienna
  Austria

• Javier Cáceres

  Medical Research Council (MRC)
  Edinburgh (Scotland)

• Tom Cooper

  Baylor College of Medicine
  Houston (USA)

• Carlo Croce

  Human Cancer Genetics Program, Ohio State University
  USA

• Manel Esteller

  Programa de Epigenética y Biología del Cáncer (PEBC) del Instituto de Investigaciones Biomedicas de Bellvitge (IDIBELL)
  Barcelona (Spain)

• Matthias W. Hentze

  The European Molecular Biology Laboratory (EMBL)
  Germany

• Susanna Obad

  MicroRNA Research at Santaris Pharma
  Denmark

• Adrian Krainer

  Cold Spring Harbor Laboratory (CSHL)
  USA

• Andreas Kulozik

  Kinderklinik University Heidelberg
  Germany

• Gunter Meister

  Department of Biochemistry I, Faculty of Biology and Preclinical Medicine, University of Regensburg
  Germany

• Johan Rinn

  Beth Israel and Deaconess Medial Center and Harvard Medical School and The Broad Institute of Harvard and MIT
  USA

• Mayka Sanchez

  Institute for Predictive and Personalized Medicine of Cancer (IMPPC, RNAREG)
  Barcelona (Spain)

• Lauro Sumoy

  Institute for Predictive and Personalized Medicine of Cancer (IMPPC)
  Barcelona (Spain)

• Luigi Naldini

  San Raffaele Telethon Institute for Gene Therapy
  Italy